Related Experiment Video
Updated: Jan 21, 2026

Permanent Cerebral Vessel Occlusion via Double Ligature and Transection
Published on: July 21, 2013
Antiplatelet Therapy in Cerebral Small Vessel Disease
Danielle de Sa Bouasquevisque1, Oscar R Benavente2, Ashkan Shoamanesh3
1Marta and Owen Boris Chair in Stroke Research and Care, Hemorrhagic Stroke Research Program, C4-118, David Braley Cardiac, Vascular and Stroke Research Institute, McMaster University/Population Health Research Institute, 237 Barton St. East, Hamilton, Ontario, L9G 1J8, Canada.
Purpose Of Review:
We critically evaluate the evidence for the use of antiplatelet therapy for stroke prevention following lacunar stroke and in patients with hemorrhage-prone cerebral small vessel disease.
Recent Findings:
Pooled lacunar stroke subgroup analyses of all relevant randomized controlled trials to date suggest a 22% relative risk reduction in recurrent stroke by single antiplatelet therapy (RR 0.77, 95% CI 0.62-0.97) compared with placebo, no consistent suggestion of variable efficacy amongst specific antiplatelet agents, and the absence of clear benefit with dual over single antiplatelet therapy. Current data does not support withholding antiplatelet therapy where otherwise indicated in patients with cerebral microbleeds on MRI or those who have suffered intracerebral hemorrhage. Antiplatelet monotherapy appears to provide persistent secondary stroke prevention in patients with lacunar stroke. Whether phosphodiesterase inhibitors, particularly cilostazol, provide additional advantage in patients with cerebral small vessel disease is worthy of further investigation.
Insights
Single antiplatelet therapy significantly reduces recurrent stroke risk in patients with lacunar stroke. This approach appears safe and effective, even in those with cerebral small vessel disease or prior hemorrhage.
Area of Science:
- Neurology
- Cardiovascular Research
- Stroke Medicine
Background:
- Lacunar stroke and cerebral small vessel disease (CSVD) are significant causes of recurrent stroke.
- Effective secondary prevention strategies are crucial for managing these conditions.
Purpose of the Study:
- To critically evaluate the evidence for antiplatelet therapy in preventing recurrent stroke after lacunar stroke.
- To assess the utility of antiplatelet therapy in patients with hemorrhage-prone CSVD.
Main Methods:
- Pooled subgroup analyses of randomized controlled trials (RCTs) involving patients with lacunar stroke.
- Review of current data regarding antiplatelet use in patients with CSVD and hemorrhage history.
Main Results:
- Single antiplatelet therapy demonstrated a 22% relative risk reduction in recurrent stroke compared to placebo.
- No significant difference in efficacy was observed among specific antiplatelet agents.
- Dual antiplatelet therapy did not show a clear benefit over single therapy.
- Antiplatelet therapy is not contraindicated in patients with cerebral microbleeds or prior intracerebral hemorrhage.
Conclusions:
- Antiplatelet monotherapy provides sustained secondary stroke prevention for lacunar stroke patients.
- Further research is warranted to explore the potential benefits of phosphodiesterase inhibitors, like cilostazol, in CSVD.
- Current evidence supports the use of antiplatelet therapy as a cornerstone of secondary stroke prevention in this population.
More Related Videos
Related Concept Videos
Gene Therapy
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure of Blood Vessels
Anatomy of Blood Vessels
Arteries
Arteries circulate oxygenated blood from the heart, except the pulmonary artery, which transports deoxygenated blood to the lungs. Large arteries, such as the aorta,...
Group Therapy

